From the patient perspective: The economic value of seasonal and H1N1 influenza vaccination
- 3 March 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (11), 2149-2158
- https://doi.org/10.1016/j.vaccine.2010.12.078
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- The 2009 H1N1 Pandemic Influenza Virus: What Next?mBio, 2010
- Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstaclesVaccine, 2010
- Economic Value of Seasonal and Pandemic Influenza Vaccination during PregnancyClinical Infectious Diseases, 2009
- How the Medicare Part D Drug Benefit Changed the Distribution of Out-of-Pocket Pharmacy Spending Among Older BeneficiariesThe Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 2009
- Antiviral Medications for Pregnant Women for Pandemic and Seasonal InfluenzaObstetrics & Gynecology, 2009
- Alternative vaccination locations: Who uses them and can they increase flu vaccination rates?Vaccine, 2009
- The Effect of Medicare Part D on Drug and Medical SpendingNew England Journal of Medicine, 2009
- Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study DataAmerican Journal of Epidemiology, 2008
- Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimumProceedings of the National Academy of Sciences of the United States of America, 2007
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer ProtectionThe Milbank Quarterly, 2006